WINNIPEG, Sept. 11 /PRNewswire-FirstCall/ - IMRIS (TSX: IM) announced today the sale of their flagship product, IMRISneuro, to one of the world's leading neuroscience centers, The Johns Hopkins Hospital in Baltimore, Maryland.
IMRISneuro is a fully integrated operating room including the IMRIS one-of-a kind, movable high field MRI. The new technology allows surgeons to safely image patients in the operating room during brain surgery, helping to rule out complications before the patient leaves the OR.
"The selection of IMRISneuro by a leading institution like Johns Hopkins is another clear indication of the value our system offers, as well as its growing acceptance as a mainstream product in neuroscience centers around the world," said David Graves, President and Chief Executive Officer of IMRIS.
IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions designed to measurably improve patient outcomes. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to move in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons around the world for use in world-class neuroscience centers.
For more information, visit http://www.imris.com
About Johns Hopkins Hospital:
The Johns Hopkins Hospital has been ranked the number one hospital for 18 consecutive years in U.S. News & World Report's annual rankings of America's best hospitals. In the magazine's specialty rankings, Johns Hopkins neurology and neurosurgery have consistently ranked in the top two.
|SOURCE IMRIS Inc.|
Copyright©2008 PR Newswire.
All rights reserved